Cerebral Small Vessel Disease Registry Study

Last updated: September 26, 2023
Sponsor: Bin Cai
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04318119
MRCTA,ECFAH of FMU [2019]245
  • Ages 18-100
  • All Genders

Study Summary

The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Small Vessel Disease (CSVD) and in a prospective multicenter study, to assess the clinical, genetic and epigenetic features of patients with CSVD, , to find independent imaging markers, and to optimize clinical management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Sign informed consent.
  2. Age>18
  3. At least one of the following CSVD MRI characteristics: ①recent small subcorticalinfarct;②lacune of presumed vascular origin;③white matter hypertensity of presumedvascular origin;④perivascular space;⑤cerebral microbleeds;⑥brain atrophy

Exclusion

Exclusion Criteria:

  1. Unable to cooperate with inspectors
  2. Non-vascular white matter lesions
  3. Other cognitive diseases (such as alzheimer's disease, Parkinson's disease or thyroiddisease)
  4. Serious systemic illness, such as heart, liver, kidney disease or major mental illness
  5. Contraindications for imaging examination

Study Design

Total Participants: 3000
Study Start date:
November 18, 2019
Estimated Completion Date:
November 18, 2055

Connect with a study center

  • Department of Neurology , First Affiliated Hospital Fujian Medical University

    Fuzhou, Fujian 350004
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.